Basic Information About DATA
On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of schedule III, IV or V opioid treatment drugs that are approved by the FDA for maintenance or detoxification treatment.
NIDA/SAMHSA Announcement & Press Release
NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. NIDA SAMHSA Press Release, October 9, 2002.
Federal Government Information
The SAMHSA, CSAT and FDA websites contains valuable information about Buprenorphine for physicians, patients and healthcare professionals that want to know more about buprenorphrine.
Find a Physician
CSAT’s Buprenorphrine Physician Locator
Guidelines
|
|
Patient Brochure
|
Introducing Office-Based Treatment for Opioid Addiction
|
Publications
Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone.
Comments by Andrew Byrne, September 23, 2003. (Published in NEJM (2003) 349:949-958).
Doctors Still Waiting to Test Buprenorphine’s Promise.
Join Together Online, January 21, 2003.
Buprenorphine treats opiate addiction in office; Two Sublingual Formulations Approved.
Mechcatie, E. Family Practice News November 15, 2002 32(22): 7.
Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office . Federation of State Medical Boards (FSMB) of the United States. Adopted April 2002.
Using buprenorphine for office-based treatment of opioid addiction.
Recommendations to the Center of Substance Abuse Treatment (CSAT) of the Substance Abuse and Mental Health Services Administration (SAMHSA), from CSAT’s National Advisory Council. September 15, 1999.
Buprenorphine An Alternative Treatment for Opioid Dependence.
Blaine, J. (editor). NIDA Research Monograph 121. Rockville: DHHS, 1992.
Pain Management, November 22, 2004.
Reckitt Benckiser Form Letter.
New Paths to Recovery.
New York City Forum, August 4, 2003.
(full transcript)
Buprenorphrine.
Kleber, H. Presented at New Paths to Recovery. New York: August 4, 2003.
Viewers and Readers
r>
|
|
|
|
|
|
|
|
|